Ellis Investment Partners’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,850
| Closed | -$20K | – | 579 |
|
|
2022
Q3 | $20K | Hold |
6,850
| – | – | 0.01% | 488 |
|
|
2022
Q2 | $25K | Hold |
6,850
| – | – | 0.01% | 478 |
|
|
2022
Q1 | $42K | Buy |
6,850
+600
| +10% | +$3.68K | 0.01% | 437 |
|
|
2021
Q4 | $50K | Hold |
6,250
| – | – | 0.01% | 424 |
|
|
2021
Q3 | $93K | Hold |
6,250
| – | – | 0.02% | 320 |
|
|
2021
Q2 | $78K | Sell |
6,250
-1,500
| -19% | -$18.7K | 0.02% | 340 |
|
|
2021
Q1 | $35K | Sell |
7,750
-10,100
| -57% | -$45.6K | 0.01% | 435 |
|
|
2020
Q4 | $38K | Buy |
17,850
+15,600
| +693% | +$33.2K | 0.01% | 413 |
|
|
2020
Q3 | $5K | Hold |
2,250
| – | – | ﹤0.01% | 626 |
|
|
2020
Q2 | $3K | Hold |
2,250
| – | – | ﹤0.01% | 653 |
|
|
2020
Q1 | $1K | Hold |
2,250
| – | – | ﹤0.01% | 688 |
|
|
2019
Q4 | $5K | Sell |
2,250
-1,000
| -31% | -$2.22K | ﹤0.01% | 594 |
|
|
2019
Q3 | $10K | Hold |
3,250
| – | – | ﹤0.01% | 536 |
|
|
2019
Q2 | $19K | Buy |
+3,250
| New | +$19K | 0.01% | 450 |
|